Giants outfielder Jose Guillen linked to HGH shipments

9 Comments

Some breaking news here from Michael S. Schmidt of the New York Times.

Giants outfielder Jose Guillen was left off San Francisco’s postseason roster this month not because of his poor play, but because he is being investigated currently for ties to performance-enhancing drugs.

According to Schmidt’s report, Guillen had packages of human growth hormone (HGH) sent to an address that is registered to his wife in the Bay Area during the 2010 season.  Major League Baseball immediately opened an investigation and recommended to the Giants that Guillen be left off the club’s postseason roster.  The Giants complied and the investigation goes on.

Few people have agreed to comment on the story and Guillen should be viewed as innocent until proven guilty, but it wouldn’t be the first time that the veteran outfielder has been linked to performance-enhancers.  The San Francisco Chronicle discovered in 2007 that Guillen bought more than $19,000 worth of HGH between 2002 and 2005.

All of this could lead to a 50-game suspension for the 34-year-old impending free agent.   He slugged 19 home runs and tallied 77 RBI in 524 at-bats this past season, but he no longer plays good defense and it’s highly probable that Guillen won’t be available for the fist few months of 2011.  It’s going to be tough for him to find a contract before the start of next year’s regular season.

Report: Yankees to promote Gleyber Torres

Yankees Torres Baseball
AP Images
2 Comments

Yankees top prospect Gleyber Torres will be promoted to the majors this weekend, per a report from Jack Curry of the YES Network. Torres was expected to make his debut earlier in the season, but his starting date was pushed back after he suffered a bout of back tightness last Monday. Now, however, it looks like he’s finally healthy enough to make an impact on a team that’s in sore need of an offensive boost. As of Saturday evening, the team has yet to officially confirm the move.

The 21-year-old infielder has made quite the impression in Triple-A Scranton/Wilkes-Barre this spring, slashing .370/.415/.543 with five extra-base hits and 11 RBI in his first 53 plate appearances. Prior to the start of the 2018 season, he was ranked first overall in the Yankees’ system and fifth among the league’s best prospects (via MLB Pipeline). His numbers at the plate have been made all the more impressive by the fact that he’s only 10 months removed from Tommy John surgery on his non-throwing arm; neither the injury nor the lengthy recovery process seems to have had any detrimental effect on his game play this year.

While Torres appears most comfortable as a shortstop, he’s not expected to supplant Didi Gregorius in a starting role. Instead, it’s more likely that he’ll sub in at second and third base among the likes of Miguel Andujar, Neil Walker and Ronald Torreyes.